To the full analysis
Buyback calculator for Gilead Sciences
Gilead Sciences stock: key metrics
GILDGilead Sciences had an operating margin of 39.7% and a return on invested capital (ROIC) of 28.1% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 12 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2006 | 85.7% | −25.1% | −39.3% |
| 2007 | 81.8% | 51.2% | 38.2% |
| 2008 | 78.9% | 50.2% | 37.1% |
| 2009 | 77.2% | 50.3% | 37.6% |
| 2010 | 76.5% | 49.8% | 36.5% |
| 2011 | 74.7% | 45.2% | 33.4% |
| 2012 | 74.5% | 41.3% | 26.7% |
| 2013 | 74.5% | 40.4% | 27.5% |
| 2014 | 84.8% | 61.3% | 48.6% |
| 2015 | 87.7% | 68.0% | 55.5% |
| 2016 | 86.0% | 58.0% | 44.4% |
| 2017 | 83.3% | 54.1% | 17.7% |
| 2018 | 78.1% | 37.1% | 24.7% |
| 2019 | 79.2% | 19.1% | 24.0% |
| 2020 | 81.5% | 16.5% | 0.5% |
| 2021 | 75.8% | 36.3% | 22.8% |
| 2022 | 79.3% | 26.9% | 16.8% |
| 2023 | 76.0% | 28.0% | 20.9% |
| 2024 | 78.3% | 5.8% | 1.7% |
| 2025 | 78.8% | 39.7% | 28.9% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2006 | −65.5% | −25.6% | −29.1% |
| 2007 | 46.7% | 50.6% | 27.7% |
| 2008 | 46.3% | 52.1% | 28.5% |
| 2009 | 41.4% | 53.3% | 27.2% |
| 2010 | 49.5% | 43.0% | 25.0% |
| 2011 | 41.6% | 47.9% | 16.2% |
| 2012 | 27.9% | 27.9% | 12.2% |
| 2013 | 27.0% | 20.4% | 13.6% |
| 2014 | 78.4% | 72.2% | 34.9% |
| 2015 | 97.7% | 83.1% | 35.0% |
| 2016 | 71.5% | 46.1% | 23.7% |
| 2017 | 22.6% | 22.7% | 6.6% |
| 2018 | 25.5% | 24.3% | 8.6% |
| 2019 | 23.9% | 20.6% | 8.7% |
| 2020 | 0.7% | 6.3% | 0.2% |
| 2021 | 29.5% | 17.8% | 9.2% |
| 2022 | 21.6% | 14.2% | 7.3% |
| 2023 | 24.8% | 15.5% | 9.1% |
| 2024 | 2.5% | 3.1% | 0.8% |
| 2025 | 37.5% | 28.1% | 14.4% |
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 11 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 28 Aug 2026)
- Valuation signal Fairly valued since 11 Nov 2026, previously Undervalued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.